Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05319535 · ClinicalTrials.gov registry record · NA

Implementing a Skills-Based Caregiver Training Program (Caregivers FIRST): Function QUERI 2.0

A NA study of Cognitive Function and Functional Status, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT05319535: Completed NA study of Cognitive Function and Functional Status, sponsored by VA Office of Research and Development.

NCT05319535 is a NA study of Cognitive Function and Functional Status that has completed, run by VA Office of Research and Development. The registered enrollment target is 25 participants, below the 496-participant average among 20 other Cognitive Function trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05319535, a NA study of Cognitive Function and Functional Status, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

Implementing a Skills-Based Caregiver Training (Caregivers FIRST): Function QUERI 2.0 aims to compare implementation strategies for large-scale spread of Caregivers FIRST, a group training for friend or family caregivers of Veterans. The goal is to use a type III effectiveness-implementation hybrid design framework to compare continuation of implementation strategies for 24 sites that do not meet implementation adoption benchmarks.

Primary Outcome

Penetration is defined as the 1) percentage of caregivers who received consults for VA caregiver education and training services who attended at least one class.

Interventions

  • OTHER Implementation Strategy: Foundational REP
  • OTHER Implementation Strategy: Enhanced REP

Study Locations (1)

North Carolina

  • Durham VA Medical Center, Durham, NC - Durham

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2022-04-25
Est. Completion 2024-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT05319535 record still lists

NCT05319535 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 496-participant average among 20 other Cognitive Function trials with a reported enrollment target (95% lower).

The record links to 2 conditions, with Cognitive Function appearing as the primary indexed condition, and to 2 interventions - of which Implementation Strategy: Foundational REP is the first listed.

NCT05319535 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05319535 about?

NCT05319535 is a clinical study titled "Implementing a Skills-Based Caregiver Training Program (Caregivers FIRST): Function QUERI 2.0". Implementing a Skills-Based Caregiver Training (Caregivers FIRST): Function QUERI 2.0 aims to compare implementation strategies for large-scale spread of Caregivers FIRST, a group training for friend or family caregivers of Veterans. The goal is to use a type III effectiveness-implementation hybrid ...

What is the current status of trial NCT05319535?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-04-25. Estimated completion is 2024-09-30.

What conditions does trial NCT05319535 study?

This clinical trial studies the following conditions: Cognitive Function, Functional Status.

What interventions are being tested in trial NCT05319535?

The interventions under investigation include: Implementation Strategy: Foundational REP (OTHER), Implementation Strategy: Enhanced REP (OTHER).

Who is sponsoring clinical trial NCT05319535?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05319535 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cognitive Function

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05319535's enrollment target sits among peer trials

25 17th of 20 higher than 4 of 20 other Cognitive Function trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cognitive Function trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05319535, the US trial registry maintained by the National Library of Medicine. NCT05319535 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.